SEC 13F Intelligence

Stenham Asset Management Ltd / ASND

Stenham Asset Management Ltd’s Ascendis Pharma A/S Position

Does Stenham Asset Management Ltd own Ascendis Pharma A/S (ASND)? Not currently — the last reported position was 19.4K shares worth $3M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q1 2021
Shares
19.4K
% of Portfolio
+1.76%
Quarters Held
2
position exited

Position History ASND

Reported value by quarter
Q4 ’20: $5MQ4 ’20Q1 ’21: $3MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202119.4K$3M+1.76%
Q4 202029.0K$5M+4.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stenham Asset Management Ltd’s full portfolio or all institutional holders of ASND.